Biotech entrepreneurs embrace crowdfunding

Crowd Funding Concept.
Share This Post

Millions of pounds are pouring into fledgling UK life science companies through crowdfunding platforms, providing a new financing option for early-stage biotechnology entrepreneurs trying to commercialise medical innovations. Cambridgeshire-based Axol Bioscience is the latest to use equity crowdfunding to bridge the notorious “valley of death” — the funding gap that often imperils start-up companies, especially in the biotech sector. Axol, which produces customised human cells for use in medical research, is seeking £600,000 through an equity crowdfunding platform called SyndicateRoom which has raised over £16m for life science companies.

To read the full article, click

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>